샘플 요청 목록

 카트 문의
시장보고서
상품코드
1643510

세계의 환자 참여 분야 인공지능 시장

Artificial Intelligence in Patient Engagement
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 248 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

환자 참여 분야 인공지능 세계 시장, 2030년까지 231억 달러에 달할 전망

2024년에 80억 달러로 추정되는 환자 참여 분야 인공지능 세계 시장은 2024년부터 2030년까지 연평균 19.4%의 CAGR로 성장하여 2030년에는 231억 달러에 달할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 클라우드 기반 전송 모드 부문은 CAGR 21.7%를 기록하여 분석 기간 종료 시점에 184억 달러에 도달할 것으로 예측됩니다. 온프레미스 제공 모드 부문의 성장률은 분석 기간 동안 CAGR 12.8%로 추정됩니다.

미국 시장은 21억 달러, 중국은 CAGR 18.3%로 성장 전망

미국의 환자 참여 인공지능 시장 규모는 2024년 21억 달러에 달할 것으로 예상됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 35억 달러의 시장 규모에 도달할 것으로 예상되며, 2024-2030년 분석 기간 동안 18.3%의 CAGR(연평균 18.3%)을 기록할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 18.0%와 16.4%의 CAGR을 기록할 것으로 예상됩니다. 유럽에서는 독일이 약 13.0%의 CAGR로 성장할 것으로 예상됩니다.

세계 환자 참여 인공지능 시장 - 주요 동향 및 촉진요인 정리

AI가 환자 참여를 어떻게 변화시킬 것인가?

인공지능(AI)은 개인화된 치료를 제공하고, 커뮤니케이션을 개선하며, 환자가 자신의 건강 관리에 적극적인 역할을 할 수 있도록함으로써 환자 참여에 혁명을 일으키고 있습니다. 기존의 환자 참여 방식은 수작업과 표준화된 접근 방식에 의존하는 경우가 많아 환자 개개인의 니즈에 효과적으로 대응하지 못했지만, AI는 머신러닝(ML), 자연어 처리(NLP), 예측 분석을 활용하여 이러한 문제를 해결하고, 맞춤형의 의미 있는 환자 경험을 제공할 수 있습니다. 맞춤형의 의미 있는 환자 경험을 실현합니다.

AI 기반 챗봇과 가상 비서는 24시간 365일 24시간 지원을 제공하고, 환자 문의에 대한 답변, 예약 예약, 투약 알림을 보내주는 등 다양한 기능을 제공합니다. 이러한 도구는 의료 서비스 제공자의 관리 부담을 줄이면서 접근성을 향상시킵니다. 또한, AI 시스템은 환자 데이터를 분석하여 개인화된 건강 제안을 제공함으로써 참여 전략이 개인의 취향과 병력에 부합하는지를 확인할 수 있습니다.

또한 AI는 모바일 앱, 포털, 웨어러블 기기를 통해 맞춤형 컨텐츠를 제공함으로써 환자 교육을 강화합니다. 이러한 플랫폼은 건강 상태, 치료 옵션, 생활습관 변화에 대한 인사이트를 제공하여 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다. AI는 지속적이고 맥락에 맞는 참여를 가능하게함으로써 환자와 의료 서비스와의 관계 방식을 변화시키고 있습니다.

환자 참여에 있어 AI 도입의 원동력은 무엇인가?

개인화되고 효율적인 헬스케어 경험에 대한 수요가 증가하면서 환자 참여에 AI를 도입하는 데 큰 원동력이 되고 있습니다. 환자들이 자신의 필요에 맞는 맞춤형 치료를 원하는 경향이 높아짐에 따라, AI 기반 솔루션은 환자 만족도와 치료 결과를 향상시키는 맞춤형 커뮤니케이션과 지원을 제공합니다. 이러한 도구는 디지털에 익숙한 환자부터 더 많은 안내를 필요로 하는 환자까지 다양한 환자 선호도를 충족시킬 수 있습니다.

원격의료 및 원격진료 모델의 부상도 AI 도입에 박차를 가하고 있습니다. 가상 진료가 보편화되면서 AI 기반 플랫폼은 환자들에게 자가 모니터링, 증상 추적, 가상 후속 조치를 위한 도구를 제공함으로써 그 격차를 메우고 있습니다. 이러한 기능을 통해 원격지나 의료 서비스가 부족한 지역의 환자들의 접근성을 향상시키면서 치료의 연속성을 보장할 수 있습니다.

또한, 데이터 통합과 상호운용성의 발전으로 AI 시스템은 여러 접점에서 원활한 환자 참여를 제공할 수 있게 되었습니다. EHR, 웨어러블 기기, 건강 앱의 데이터를 분석함으로써 AI는 환자의 페이센트 여정을 통합적으로 파악하여 일관되고 영향력 있는 상호 작용을 가능하게 합니다. 이러한 추세는 환자 참여 전략을 재구축하는 데 있어 AI의 중요성이 커지고 있음을 보여줍니다.

AI가 건강 결과와 환자 만족도를 높일 수 있을까?

AI는 사전 예방적이고 개인화된 치료를 촉진하여 건강 결과와 환자 만족도를 크게 향상시키고 있습니다. 예측 분석 도구는 만성질환 및 합병증 위험이 있는 환자를 식별하여 적시에 개입하고 입원 가능성을 낮출 수 있도록 돕습니다. 예를 들어, AI 시스템은 활력 징후와 생활습관 데이터를 모니터링하고 당뇨병이나 심장병과 같은 질병의 조기 경고 신호를 감지하여 의료 서비스 제공자가 예방 조치를 취할 수 있도록 돕습니다.

AI는 일상적인 업무를 자동화하고 진료 조정을 개선함으로써 종종 환자의 불만을 야기하는 관리상의 비효율성을 줄일 수 있습니다. 실시간 업데이트, 자동 예약 알림, 의료 정보에 대한 손쉬운 액세스를 통해 환자는 항상 정보를 얻고 치료에 참여할 수 있습니다. 이러한 기능은 환자의 전반적인 경험을 개선하고 치료 계획의 순응도를 높입니다.

AI는 또한 스트레스 관리, 마음챙김, 행동 치료를 위한 도구를 제공함으로써 정신건강과 웰빙을 지원할 수 있습니다. 가상 비서는 환자 치료의 정서적 측면에 대응하고 개인화된 추천과 대처 전략을 제공합니다. 이러한 기술 혁신은 전인적 건강 관리에 기여하고 신체적, 정신적 웰빙을 향상시킬 수 있습니다.

환자 참여 AI 시장의 성장 원동력은 무엇인가?

환자 참여 분야 인공지능(AI) 시장 성장은 헬스케어 분야의 혁신 가능성을 반영하는 몇 가지 중요한 요인에 의해 주도되고 있습니다. 환자 중심 진료 모델에 대한 관심이 높아지면서 의료 서비스 제공자들은 커뮤니케이션을 개선하고 개인화된 경험을 제공하기 위해 AI 도구를 도입하고 있습니다. 이러한 솔루션은 조직이 환자와의 관계를 강화하고 충성도와 신뢰도를 높이는 데 도움이 될 수 있습니다.

머신러닝, NLP, 실시간 분석과 같은 AI 기술 발전은 환자 참여 플랫폼의 기능을 확장하고 있습니다. 이러한 도구는 의료 서비스 제공자가 환자의 요구를 예측하고 사전 예방적 지원을 제공할 수 있는 실용적인 인사이트를 제공합니다.

디지털 건강 솔루션에 대한 선호도가 높아지는 등 소비자 행동 트렌드가 시장 성장을 더욱 촉진하고 있습니다. 환자들은 모바일 앱, 웨어러블 기기, 가상 비서를 건강 관리를 위한 효과적인 도구로 받아들이고 있습니다. 또한, 가치 기반 의료 및 환자 참여 이니셔티브를 촉진하는 규제적 인센티브가 헬스케어 분야에서의 AI 채택을 촉진하고 있습니다.

이러한 요인들은 디지털 헬스 기술에 대한 투자 증가와 함께 환자 참여에 대한 AI 시장의 급속한 확장을 촉진하고 있으며, 의료 제공 및 환자 중심 서비스의 미래 혁신의 초석으로 자리매김하고 있습니다.

부문

제공 형태(클라우드 기반 제공 형태, 온프레미스 제공 형태), 기능(커뮤니케이션 강화 기능, 챗봇 & 가상 건강 도우미 기능, 예측 분석 기능, 환자 교육 기능, 기타 기능), 기술(자연어 처리(NLP) 기술, 기타 기술), 치료 영역(만성질환 관리 치료 영역, 건강 및 웰니스 치료 영역, 기타 치료 영역), 최종사용자(의료 공급자 최종사용자, 의료 지불자 최종사용자, 기타 최종사용자)

조사 대상 기업 사례(주목 52개사)

  • Ada Health GmbH
  • AiCure
  • Aiva
  • AllazoHealth
  • Brand Engagement Network, Inc.
  • Claritas Rx
  • EmpiRx Health, LLC.
  • Health Catalyst
  • Huma
  • IBM Corporation

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

ksm 25.02.14

Global Artificial Intelligence in Patient Engagement Market to Reach US$23.1 Billion by 2030

The global market for Artificial Intelligence in Patient Engagement estimated at US$8.0 Billion in the year 2024, is expected to reach US$23.1 Billion by 2030, growing at a CAGR of 19.4% over the analysis period 2024-2030. Cloud-based Delivery Mode, one of the segments analyzed in the report, is expected to record a 21.7% CAGR and reach US$18.4 Billion by the end of the analysis period. Growth in the On-Premise Delivery Mode segment is estimated at 12.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 18.3% CAGR

The Artificial Intelligence in Patient Engagement market in the U.S. is estimated at US$2.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.5 Billion by the year 2030 trailing a CAGR of 18.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 18.0% and 16.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.0% CAGR.

Global Artificial Intelligence in Patient Engagement Market - Key Trends & Drivers Summarized

How Is AI Transforming Patient Engagement?

Artificial Intelligence (AI) is revolutionizing patient engagement by delivering personalized care, improving communication, and empowering patients to take an active role in their health management. Traditional patient engagement methods often rely on manual interactions and standardized approaches that fail to address individual needs effectively. AI addresses these challenges by leveraging machine learning (ML), natural language processing (NLP), and predictive analytics to create tailored and meaningful patient experiences.

AI-powered chatbots and virtual assistants provide 24/7 support, answering patient queries, scheduling appointments, and sending medication reminders. These tools enhance accessibility while reducing the administrative burden on healthcare providers. In addition, AI systems analyze patient data to offer personalized health recommendations, ensuring that engagement strategies align with individual preferences and medical histories.

Moreover, AI enhances patient education by delivering customized content through mobile apps, portals, and wearable devices. These platforms provide insights into health conditions, treatment options, and lifestyle changes, fostering informed decision-making. By enabling continuous and context-aware engagement, AI is transforming the way patients interact with healthcare services.

What Drives the Adoption of AI in Patient Engagement?

The growing demand for personalized and efficient healthcare experiences is a major driver of AI adoption in patient engagement. As patients increasingly seek customized care that addresses their unique needs, AI-powered solutions offer tailored communication and support that enhances satisfaction and outcomes. These tools cater to diverse patient preferences, from digital-savvy individuals to those requiring more guidance.

The rise of telemedicine and remote care models is also fueling AI adoption. With virtual consultations becoming more prevalent, AI-driven platforms bridge the gap by providing patients with tools for self-monitoring, symptom tracking, and virtual follow-ups. These capabilities ensure continuity of care while improving access for patients in remote or underserved areas.

Additionally, advancements in data integration and interoperability are enabling AI systems to provide seamless patient engagement across multiple touchpoints. By analyzing data from electronic health records (EHRs), wearable devices, and health apps, AI creates a unified view of the patient journey, ensuring consistent and impactful interactions. These trends underscore the growing importance of AI in reshaping patient engagement strategies.

Can AI Enhance Health Outcomes and Patient Satisfaction?

AI is significantly enhancing health outcomes and patient satisfaction by fostering proactive and personalized care. Predictive analytics tools identify patients at risk of chronic conditions or complications, enabling timely interventions and reducing the likelihood of hospitalizations. For example, AI systems monitor vital signs and lifestyle data to detect early warning signs of conditions such as diabetes or heart disease, allowing healthcare providers to take preventive action.

By automating routine tasks and improving care coordination, AI reduces administrative inefficiencies that often lead to patient dissatisfaction. Real-time updates, automated appointment reminders, and easy access to medical information empower patients to stay informed and engaged in their care. These capabilities enhance the overall patient experience while ensuring better adherence to treatment plans.

AI also supports mental health and well-being by providing tools for stress management, mindfulness, and behavioral therapy. Virtual mental health assistants deliver personalized recommendations and coping strategies, addressing the emotional aspects of patient care. These innovations contribute to holistic health management, improving both physical and mental well-being.

What’s Driving the Growth of the AI in Patient Engagement Market?

The growth in the Artificial Intelligence in Patient Engagement market is driven by several critical factors, reflecting its transformative potential in healthcare. The increasing focus on patient-centric care models is encouraging healthcare providers to adopt AI tools that improve communication and deliver personalized experiences. These solutions help organizations build stronger relationships with patients, enhancing loyalty and trust.

Technological advancements in AI, including machine learning, NLP, and real-time analytics, are expanding the capabilities of patient engagement platforms. These tools provide actionable insights that enable healthcare providers to anticipate patient needs and deliver proactive support.

Consumer behavior trends, such as the growing preference for digital health solutions, are further driving market growth. Patients are embracing mobile apps, wearable devices, and virtual assistants as tools to manage their health effectively. Additionally, regulatory incentives promoting value-based care and patient engagement initiatives are supporting the adoption of AI in healthcare.

These factors, coupled with increasing investments in digital health technologies, are propelling the rapid expansion of the AI in Patient Engagement market, positioning it as a cornerstone of future innovation in healthcare delivery and patient-centric services.

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence in Patient Engagement market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Delivery Mode (Cloud-based Delivery Mode, On-Premise Delivery Mode); Functionality (Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality, Other Functionalities); Technology (Natural Language Processing (NLP) Technology, Other Technologies); Therapeutic Area (Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area, Other Therapeutic Areas); End-Use (Healthcare Providers End-Use, Healthcare Payers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 52 Featured) -

  • Ada Health GmbH
  • AiCure
  • Aiva
  • AllazoHealth
  • Brand Engagement Network, Inc.
  • Claritas Rx
  • EmpiRx Health, LLC.
  • Health Catalyst
  • Huma
  • IBM Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Economic Frontiers: Trends, Trials & Transformations
    • Artificial Intelligence in Patient Engagement - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Real-Time AI Chatbots Expand Opportunities for Enhancing Patient Communication
    • AI for Personalized Health Recommendations Strengthens Case for Proactive Engagement
    • AI-Driven Virtual Health Assistants Spur Growth in Home-Based Care Models
    • AI for Appointment Scheduling Optimizes Patient Flow, Driving Market Adoption
    • AI in Medication Adherence Monitoring Highlights Opportunities in Chronic Disease Management
    • AI-Powered Health Education Platforms Expand Addressable Market for Wellness Apps
    • Growing Demand for AI in Telehealth Sets the Stage for Patient-Centric Engagement Tools
    • AI for Remote Monitoring Systems Strengthens Case for Continuous Patient Interaction
    • AI for Multilingual Support Tools Bodes Well for Global Patient Engagement Markets
    • Integration of AI in Family Health Management Strengthens Use Cases in Collaborative Care
    • AI for Seamless Billing and Insurance Queries Drives Adoption in Revenue Cycle Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Intelligence in Patient Engagement Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Intelligence in Patient Engagement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cloud-based Delivery Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Cloud-based Delivery Mode by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for On-Premise Delivery Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for On-Premise Delivery Mode by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Chronic Disease Management Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Chronic Disease Management Therapeutic Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Health & Wellness Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Health & Wellness Therapeutic Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Healthcare Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Healthcare Providers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Healthcare Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Healthcare Payers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Enhanced Communication Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Enhanced Communication Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Chatbots & Virtual Health Assistants Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Chatbots & Virtual Health Assistants Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Predictive Analytics Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Predictive Analytics Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Patient Education Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Patient Education Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Functionalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Other Functionalities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Natural Language Processing (NLP) Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Natural Language Processing (NLP) Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 34: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 42: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: USA 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 52: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Canada 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • JAPAN
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 60: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Japan 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • CHINA
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 64: China Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 70: China Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: China 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 72: China Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: China 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • EUROPE
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 82: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 84: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • FRANCE
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 88: France Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: France 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 90: France Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: France 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 94: France Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: France 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • GERMANY
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 96: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Germany 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 100: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Germany 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 102: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Germany 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • ITALY
    • TABLE 106: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Italy 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 108: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Italy 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 112: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Italy 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 114: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Italy 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 118: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 119: UK 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 120: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 121: UK 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 124: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 125: UK 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 126: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 130: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 132: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Rest of Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 136: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 138: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 142: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 143: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 144: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 145: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 148: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 149: Rest of World 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 150: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 151: Rest of World 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of World 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 154: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 155: Rest of World 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제